Caplight Directory>Investors>Xontogeny>Xontogeny


Xontogeny

Xontogeny

Boston, Massachusettsxontogeny.com

Overview

Xontogeny is a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs to drive the successful development of their technologies to enable new treatment options for patients with serious disease . Xontogeny offers its experienced team and deep network of industry consultants and service providers along with seed investment capital across a variety of technologies, including therapeutics, diagnostics, and devices with the singular goal of shepherding each program through a compelling clinical proof-of-concept study .

Year Founded

2016

Portfolio Companies

11

Investments

CompanyDateStageLead
CereVascMay 2024Series BCo-investor
TORL BioTherapeuticsApr 2024Series B Extension-
NeurosterixApr 2024Series ALead
Avalyn PharmaSep 2023Series CLead
TORL BioTherapeuticsApr 2023Series BCo-investor
View all investments

Key People

Fred Callori

Senior Partner

Gianna Hoffman-Luca

Partner

Takeru Furuya

Principal Entrepreneur-in-Residence

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.